Interventions for bullous pemphigoid.

ABSTRACT:

Background

Bullous pemphigoid (BP) is the most common autoimmune blistering disease in the West. Oral steroids are the standard treatment.This is an update of the review published in 2005.

Objectives

To assess treatments for bullous pemphigoid.

Search strategy

In August 2010 we updated our searches of the Cochrane Skin Group Specialised Register, the Cochrane Central Register of Controlled Trials (Clinical Trials), MEDLINE, EMBASE, and the Ongoing Trials registers.

Selection criteria

Randomised controlled trials of treatments for participants with immunofluorescence-confirmed bullous pemphigoid.

Data collection and analysis

At least two authors evaluated the studies for the inclusion criteria, and extracted data independently.

Main results

We incl

SUBMITTER: Kirtschig G 

PROVIDER: S-EPMC7138251 | biostudies-literature | 2010 Oct

REPOSITORIES: biostudies-literature